DermalStilbene is delivered via roll-on application onto the skin. This product contains DMSO( Dimethyl Sulfoxide) as a carrier and caution should be used when using this product near eyes. Each 10ml bottle contains 300 mg of pterostilbene. When using this product you may notice some of the following; as you roll on your skin you may feel heat sensation, and you may notice tingling or itching, this is all normal and will usually subside within 5 -10 minutes of use, although it can last longer.
Pterostilbene, (trans-3,5-dimethoxy-4-hydroxystilbene) is a stilbene compound that is structurally similar to other popular stilbenes such as resveratrol or piceatannol; it is named after its first discovered source (the pterocarpus genus) but is also a component of blueberries and grape products. It is a phytoalexin (a compound produced by plants as a defense against parasites and insects) similar to resveratrol albeit more potent. Pterostilbene has been found to be significantly more stable in vivo than resveratrol, its half-life in vivo is approximately 104 minutes versus resveratrol, for 13 minutes.
Further, studies indicate that the body better absorbs pterostilbene than resveratrol, and pterostilbene is more biologically active than resveratrol, and is more efficacious than resveratrol in inhibiting certain biological activities including pro-inflammatory enzymes (providing anti-inflammatory benefits), and cell membranes producing lipid peroxidation (providing anti-oxidant support).
Each of the benefits below are specifically a growing concern within our targeted demographics, the availability of a natural product to the existing medical protocols provides a logical and affordable alternative, without many of the adverse side effects of traditional medicines.
- Reduced insulin sensitivity
- Reduction in VLDL and LDL (bad) cholesterol levels
- Increasing HDL (good) cholesterol levels
- Positive vascular smooth muscle cells
- Anti-inflammatory benefits
- Anti-oxidant benefits
- Cognitive function improvement
- Skin protection from Ultra Violet light exposure
DermalStilbene is manufactured and sold under US Patent No.: 9,682,047